@TigerSpacTrader @cctranscripts - now if the crooked scumbag insiders at $MRNA were buying shares up here it would be a different story....gonna be hilarious if it turns out they stole the intellectual property from $ABUS --- Moderna Loses Patent Challenge: In an ongoing legal dispute, the Patent Trial and Appeal Board ruled against Moderna's challenge to the patentability of Arbutus Biopharma Corp's (NASDAQ: ABUS) ABUS'069 patent. The ‘069 patent covers liquid nanoparticle formulations, or LNPs, meant for nucleic acid delivery, which is used by Moderna in its vaccine candidates. m.benzinga.com/article/1676...